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Abstract
Background: Intervention fidelity is the degree to which interventions have been implemented as intended by
their developers. Assessing fidelity is crucial for accurate interpretation of intervention effectiveness, but fidelity is
often poorly addressed within trials of complex healthcare interventions. The reasons for this are unclear, and
information on the use of methods to enhance and assess fidelity in trials of complex interventions remains
insufficient. This study aimed to explore the knowledge, practice and attitudes towards intervention fidelity
amongst researchers, triallists and healthcare professionals involved with the design and conduct of trials of
complex healthcare interventions.
Methods: An online survey consisting of closed and open-ended questions exploring four sections (Demographics,
Fidelity knowledge, Practice and Attitudes) was conducted. This was an opportunistic sample of individuals with experience
of direct involvement in trials of complex healthcare interventions (e.g. design/development, conduct, evaluation).
Results: Data from 264 participants representing 15 countries were analysed. The majority (65.9%, n = 174) of
participants identified themselves as ‘Researchers’. The majority of participants were familiar with the term “intervention
fidelity” (69.7%, n = 184) and indicated that fidelity is important (89.7%, n = 236). Mean self-reported understanding of
fidelity was moderate. Although 68% (n = 182) had previously used strategies to assess (e.g. audio/video-recording
sessions) and enhance (e.g. training manual) fidelity in trials of complex interventions, only a limited proportion of
participants indicated always reporting these strategies in subsequent publications (30.9%, n = 56). Poor knowledge or
understanding was the most commonly cited barrier to addressing intervention fidelity in trials (77.4%, n = 202). Over
half of respondents (52.1%, n = 137) had never completed specific fidelity training or research, and the vast majority
(89.7%, n = 236) would welcome specific training in this area.
Conclusion: Despite good awareness of intervention fidelity and its importance, poor knowledge and understanding
appears to be a key factor limiting how intervention fidelity is addressed in trials of complex interventions. Participants
identified a need for further training and education in this area. Additionally, clarification of the terminology, definition
and components of intervention fidelity would facilitate better understanding of the concept. A discrepancy between
participants’ use of fidelity strategies and subsequent reporting raises concerns around inadequate fidelity reporting in
the trials literature.
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Background
Trial evaluations typically focus on understanding
whether or not interventions “work” to attain target out-
comes, with comparatively less focus on understanding
how and why interventions succeed or fail in attaining
target outcomes. Complex interventions are interven-
tions with several interacting components. This includes
aspects such as the number and difficulty of behaviours
involved, number of groups or organisational levels tar-
geted by the intervention, number and variability of out-
comes and the degree of flexibility or tailoring that the
intervention permitted [1]. Given the greater capacity
for variation in the implementation of these components
and therefore greater scope for confounding variables to
influence outcomes, the focus on understanding the how
and why is of particular importance to trials of complex
interventions [2, 3]. Intervention fidelity is the degree to
which an intervention is implemented as intended in the
original programme model or protocol by its developers
[2–7], and is crucial for accurate interpretation of inter-
vention outcomes. However, intervention fidelity is often
poorly addressed within trials of complex healthcare in-
terventions [4, 8–14]. The reasons for this are unclear,
and information on the knowledge, practice and atti-
tudes of stakeholders involved in trials of complex inter-
ventions towards methods that can be used to enhance
and assess fidelity remains insufficient.
Intervention fidelity increases the internal validity of a
trial such that the results are directly attributable to the
intervention [3, 8]. For instance, if trials demonstrate
non-significant results and did not measure fidelity, one
cannot be sure that null results were due to an ineffect-
ive intervention or intervention components that were
omitted. Similarly, if significant results were found and
fidelity not measured, one cannot be sure if the results
were due to an effective intervention or additional unin-
tended components influencing the outcome [15]. This
enables researchers to more accurately detect meaning-
ful effects and establish causal relationships by reducing
random and unintended variability. This enables a better
understanding of how and why complex interventions
have or have not worked and what the “active ingredi-
ents” of the intervention are [16, 17]. Fidelity strategies
can be considered in terms of methods to enhance or
improve fidelity of intervention implementation (e.g.
treatment manuals), and methods to assess or monitor
fidelity alongside trial outcome evaluations (e.g. provider
self-report record) [8, 10, 14–18]. Reporting the
intervention fidelity methods used in trials of complex
interventions provides practitioners with adequate infor-
mation to determine whether they are delivering the
intervention as intended in real-life settings. This also
enhances the external validity of a trial and increases re-
producibility [8].
Despite the importance of intervention fidelity within
complex interventions, numerous reviews have shown
that the quality and scope of how fidelity has been en-
hanced and assessed across multiple areas is poor [4, 8–
14]. For example, Walton et al. found that fewer than
half of the included studies measured fidelity within
complex health behaviour change interventions [13]. In
a systematic review of fidelity methods used in complex
behaviour change interventions promoting physical ac-
tivity, Lambert et al. further identified a lack of attention
to the quality of fidelity assessments, with few studies
using objective methods [14]. Another review found that
none of the 72 included articles reported either fidelity
definitions or use of conceptual frameworks [4]. This is
despite the availability of several conceptual frameworks
and methodological guidance for assessing fidelity [9, 15].
However, existing frameworks differ in several respects.
First, there is inconsistency and lack of agreement on ter-
minology [4], with terms such as intervention fidelity,
treatment fidelity, implementation fidelity and programme
adherence often used interchangeably [4, 19, 20]. Further-
more, these frameworks differ in the specific dimensions
and components that they argue constitute fidelity. None-
theless, all frameworks agree that fidelity is a multidimen-
sional concept, relevant at the intervention designer,
provider and recipient level [11, 21–23]. The National In-
stitutes of Health Behaviour Change Consortium
(NIHBCC) fidelity framework attempted to synthesise this
research, conceptualising fidelity as consisting of five do-
mains [16]. These include; study design (a study’s intended
hypotheses in relation to the underlying theory and mech-
anisms of action), training providers (referring to the pro-
viders’ ability to deliver the intervention as intended),
delivery of treatment (providers’ actual delivery of the
intended intervention) receipt of treatment (participants
understand and are able to perform intervention skills
and behaviours) and enactment (participants apply inter-
vention skills and behaviours in real life) [16]. However,
despite the comprehensiveness of the NIHBCC frame-
work, debate remains about the addition of certain fidelity
components such as treatment enactment [24] and many
still view fidelity as only ‘the delivery of the intervention
or treatment as intended’ [7, 25].
While existing reviews have documented limitations in
how fidelity has been addressed within trials of complex
interventions [4, 8–14, 23, 26], they have not investi-
gated potential reasons underpinning the lack of invest-
ment into investigating fidelity. Perepletchikova et al.
explored barriers to intervention fidelity amongst psy-
chotherapists exclusively [27], and found lack of theory
and specific guidelines, time, cost and labour to be
strong barriers to implementing fidelity procedures [27].
Other barriers identified by their survey included lack of
general knowledge and lack of editorial requirement. In
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a survey of school psychologists’ attitudes towards inter-
vention fidelity in school-based interventions for chil-
dren, Cochrane et al. found that although participants
agreed fidelity was important, only 10.7% of psycholo-
gists reported always assessing it within individual inter-
ventions [28]. Reasons for this included time constraints
and lack of understanding of and buy-in towards fidelity
by teachers. However, there is no such information on
the barriers and facilitators towards fidelity practices
within trials of healthcare complex interventions, and
the knowledge or attitudes amongst those involved in
the design and conduct of these trials. Identification of
such factors is essential to realise the potential contribu-
tion of fidelity data towards the interpretation, imple-
mentation and scalability of complex healthcare
intervention trial findings.
This study therefore sought to explore the knowledge,
practice (including barriers and facilitators to practice)
and attitudes towards addressing intervention fidelity
amongst researchers, triallists and healthcare professionals
with experience of trials of complex healthcare interven-
tions. It also sought to explore potential associations be-
tween self-reported fidelity knowledge/understanding and
attitudes towards fidelity and (1) years of experience, (2)
level of qualification and (3) research area.
Methods
Design
A cross-sectional web-based questionnaire study design
was used.
Target population
The target population was researchers, triallists and
healthcare professionals with direct involvement in trials
of complex healthcare interventions (e.g. design/develop-
ment, conduct, evaluation) but excluding study subjects/
patient participants. Such individuals could include aca-
demic researchers, research practitioners, clinicians, trial-
lists, trial methodologists and statisticians from all areas of
healthcare e.g. medicine, psychology, nursing/midwifery,
allied health professionals. Participants were identified via
professional groups, research networks and academic in-
stitutions. Complex interventions were defined as per the
Medical Research Council (MRC) definition [1], as de-
scribed previously. Participants with experience of
pharmaceutical/drug trials only were not eligible to
complete the survey as these were not considered “com-
plex interventions” as defined by the MRC guidance [1].
Questionnaire
A 34-item questionnaire (30 closed and 4 open-ended
questions) was developed by DMc and ET (Add-
itional file 1). Brief demographic and background infor-
mation was collected from the participants, for example
age, gender, country of work, area of healthcare research
etc. No personal identifying information was collected.
Survey questions were largely based on the NIHBCC
conceptualisation of fidelity, but drawing on other prom-
inent fidelity literature and previous fidelity question-
naires e.g. Carroll et al., Perepletchikova et al., Cochrane
et al., Smith et al. [2, 3, 28, 29].
Questions were piloted for content, readability and
feasibility of completion with seven researchers and re-
search practitioners from a variety of research back-
grounds including health services research, health
psychology, trials methodology, implementation science
and medical statistics. Feedback provided was mostly
minor and related to clarifying certain aspects (e.g. pro-
viding a level of involvement for research practitioner as
well as practitioner, providing an example of interven-
tion theory/hypothesised mechanisms of action), or sim-
plifying word use. Feedback from one researcher also
resulted in the inclusion of an additional question to col-
lect data on facilitators and barriers to fidelity. The final
questionnaire was structured around three sections:
1. Knowledge (5 questions)
The knowledge section asked participants whether
they were familiar with the term “intervention
fidelity”. Participants familiar with the term were
shown statements describing components of
intervention fidelity and asked to select which they
felt were fidelity components. These statements
were based on components as identified and
defined previously by the NIHBCC (i.e. definitions
of study design, provider training, treatment
delivery, treatment receipt, treatment enactment)
[15]. Two other components derived from existing
fidelity literature [11] (“ensuring that training is
given to providers as intended”, i.e. delivery of
training and “ensuring adequate difference between
the intervention and comparator groups”, i.e.
treatment differentiation) were also shown.
Participants could select more than one option or
could add additional components. Participants who
were not familiar with intervention fidelity were
asked about familiarity with provided synonymous
terms obtained from the literature [20]. Participants
could select more than one term or add additional
terms. All participants were asked to self-report
their understanding of intervention fidelity on a
scale from 1 (poor) to 10 (excellent).
2. Practice and barriers and facilitators to practice
(15 questions)
The practice section assessed participants’ previous
use of specific fidelity strategies or fidelity
frameworks and subsequent reporting (i.e.
publishing/dissemination) of strategies used or
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results of fidelity assessments. This section also
assessed the barriers and facilitators to these
specific aspects. Participants were initially provided
with the definition of intervention fidelity by Carroll
et al. as previously detailed. Examples of specific
strategies to enhance and assess fidelity such as the
use of treatment manuals (enhance) or provider
self-report record (assess) strategies as previously
recorded in the fidelity literature were shown to
participants [15, 16, 24, 30]. Participants were asked
to identify specific methods they had previously
used (if any) and could select more than one option
or describe additional strategies or select a “none”
option. Participants were also asked to rate frequency
of use of assessment strategies, enhancement
strategies and reporting of these strategies on a 5-
point scale from 1 (never) to 5 (always). Participants
were then asked if they had used specific validated
tools or frameworks to inform how fidelity might be
enhanced, assessed or reported (e.g. NIHBCC
Treatment Fidelity Framework [9]). Participants
could select more than one option or list additional
frameworks or select a “none” option. Participants
were then provided with a list of barriers (n = 14) and
facilitators (n = 11) to addressing intervention fidelity
previously identified in the literature [27, 28] (e.g. lack
of journal requirement for publication), and asked to
select which of these were barriers and/or facilitators.
Participants could select more than one option or
describe additional barriers/facilitators in free-text
responses or select a “none” option. Participants were
subsequently asked to state what they felt were the
three most important barriers and facilitators, not
limited to those from the provided list.
3. Attitudes (5 questions)
Finally, the attitudes section explored participants’
opinions of the importance of intervention fidelity,
and views on training needs regarding fidelity.
Participants were asked to rate the importance of
intervention fidelity on a 5-point scale from 1 (not
important) to 5 (very important). Participants were
asked to identify any previous training in intervention
fidelity (e.g. formal workshops, informal self-directed
research) from a list, and could select more than one
option or add other types of training. Participants
were also asked what types of training they would
avail of in future (e.g. workshops, seminars), if
any. Finally, participants were given a chance to
add any further comments on the survey or topic
in general.
Survey dissemination
The survey was hosted on Google Forms. A total of 297
organisations including healthcare professional groups,
research networks and academic institutions from 24
countries were identified. Organisations were contacted
via email containing a web link to direct potential partici-
pants to the survey. Of these, 42 replied to emails and
agreed to disseminate the survey to their members/col-
leagues. Twitter was also used to disseminate the link to
the survey using both general and targeted tweets (e.g. to
specific individuals and well-known researchers). The sur-
vey was available for completion for a total of 2 weeks and
no reminder emails were sent; however, tweets were sent
daily over this period.
Analysis
Descriptive statistics (means, standard deviations) were
used to summarise the characteristics of the respondents
and levels of knowledge, attitudes and practice of inter-
vention fidelity using SPSS Statistics v24. The survey did
not include forced response questions, i.e. participants
could proceed to the next question without responding.
Questions omitted by participants for individual ques-
tions were not imputed, with data generated only from
respondents who answered the particular question. The
relationship between years of trials-specific experience
and (1) self-reported level of knowledge/understanding
and (2) attitudes towards fidelity (self-rated importance
of fidelity) were explored using Spearman’s correlation.
Associations between level of qualification (i.e. doctoral
(PhD/DPhil), postgraduate (e.g. MSc.), up to under-
graduate (e.g. high school, BSc)), research area and (1)
self-reported level of knowledge/understanding and (2)
attitudes towards fidelity were explored using one-way
between-group analysis of variance (ANOVA). To ex-
plore “Research Area”, as participants could select more
than one area, three additional grouped categories were
created to facilitate analysis. Where participants selected
more one category from either medical, allied health
professional or nursing/midwifery variables, these were
grouped to create “medical and health professionals”. If
participants selected both health services research and
public health, these were grouped to create “public
health and health services research”. Where multiple
categories were selected that belonged to more than one
of these (i.e. psychology and health services research, or
nursing/midwifery and psychology), then they were cate-
gorised as “multidisciplinary”. Qualitative data from all
four open-ended questions were analysed using a con-
ventional content analysis approach where coding cat-
egories are derived directly from the text data, suitable
for analysing minimal qualitative data as in our study
[31]. Individual responses were summarised by the first
author (DMc) according to key emerging concepts or
thoughts. These emergent concepts were then grouped
and refined into final categories, which were then quan-
tified (i.e. how many responses), with exemplar
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responses/quotes identified for each (raw data and syn-
thesis are provided in Additional file 2). This synthesis
was then double-checked and verified by the corre-
sponding author (ET).
Ethical approval
Ethical approval for this study was granted by the Galway
Clinical Research Ethics Committee. Participants were in-
formed that participation was voluntary and assured of
the confidentiality of their responses prior to completing
the survey. Brief information on the study aims and fun-
ders was provided online at the start of the survey. Partici-
pants who subsequently provided electronic consent were
invited to continue and complete the survey.
Results
The online survey received 327 responses. Of these, 62
participants were not eligible as they self-reported no ex-
perience of trials of complex healthcare interventions,
and data for one participant were excluded as they had
experience with pharmaceutical trials only. Therefore,
data from 264 participants were included in the analysis.
Missing data for individual survey items were minimal
(Additional file 3). The mean age of participants was
40.63 (± 11.03) years, with a mean of 11.73 (± 8.67) years
of research experience. Participants from 15 countries
were included in the analysis, with 60.4% from the Re-
public of Ireland and England, combined. “Multidiscip-
linary” was the most represented area of research (43.6%
of participants), followed by “medical” (16.2% of partici-
pants). Full population demographics are included in
Table 1.
Knowledge
Of the 264 respondents, 69.7% (n = 184) were familiar
with the term “intervention fidelity”. This group were
asked to select what they felt were components of inter-
vention fidelity; the vast majority (95.7% (n = 176)) indi-
cated “ensuring the intervention is delivered as intended”
was a component, reflecting endorsement of the NIHBCC
domain “Treatment Delivery”. “Ensuring training given to
providers is conducted as intended” was the next most
commonly indicated by 73.4% (n = 135), while the least
frequently endorsed component was the NIHBCC domain
of “Treatment Enactment” (13.6% (n = 36)). As most par-
ticipants selected more than one component with a total
of 703 responses, the mean number of components re-
ported per participant was 3.82 (SD 1.93). The full list of
responses and how participants endorsed the other
NIHBCC domains is included in Fig. 1.
Of the participants who were not familiar with the
term “intervention fidelity”, 79 responded to a question
about synonyms of intervention fidelity. Of these, 70.9%
(n = 56) were familiar with the term “programme
adherence”, 54.4% (n = 43) with “implementation adher-
ence” and 49.4% (n = 39) with “procedural reliability”: 16
participants (20.3%) responded that they were not famil-
iar with any of these terms. Overall, the mean
self-reported knowledge of intervention fidelity for all
participants was 5.84 (SD 2.26) on a 10-point scale
(prior to the provision of a fidelity definition). There was
a significant positive association between years of
trials-specific research experience and self-reported
knowledge/understanding of fidelity (rho = .260, n = 261,
p < .0005) and between level of qualification and know-
ledge/understanding (F (3, 258) = 10.613, p < .0005).
People with a PhD or DPhil reported significantly
greater knowledge (mean (M) = 6.52, SD = 1.85) than
participants with a postgraduate qualification (M = 5.44,
SD = 2.47) or those achieving up to an undergraduate
qualification (M = 4.50, SD = 2.27). There also was a sig-
nificant difference in self-reported knowledge/under-
standing of fidelity based on research area (F (9, 28.566)
= 4.956, p < .0005). Participants in the medical category
self-reported significantly lower knowledge (M = 4.37,
SD = 2.53) than those in psychology (M = 6.91, SD =
1.04), public health (M = 7.00, SD = 1.60), health services
research (M = 6.38, SD = 1.43) and multidisciplinary (M
= 6.38, SD = 2.00).
Practice
The majority (68.9%, n = 182) of participants had previ-
ous experience of using strategies to assess and/or en-
hance fidelity in trials of complex interventions. In
terms of how frequently these strategies are used, on a
scale of 1 (never) to 5 (always), the mean frequency of
use of assessment and enhancement strategies were 3.33
(± 1.02) and 3.39 (± 1.02), respectively. 44.2% of partici-
pants (n = 80) selected “always” or “frequently” using as-
sessment strategies and 48.6% (n = 88) selecting the
same with respect to enhancement strategies. Using the
same scale, the mean frequency of reporting the use of
fidelity strategies in publication was 2.93 (± 1.05) with
30.9% (n = 56) selecting “always” or “frequently” report-
ing. The full response to the use of strategies to assess,
enhance and report fidelity is presented in Fig. 2.
The mean frequency of reporting the overall results of
fidelity assessments (i.e. quantifying the levels of fidelity)
was 2.89 (± 1.15) with 29.2% (n = 53) selecting “always” or
“frequently” reporting. Strategies that participants had
previously used to assess (n = 181) and enhance (n = 182)
fidelity are detailed in Table 2. The most frequently
used assessment strategies were provider self-report
record (n = 115), direct observation (n = 106) and par-
ticipant interview (n = 106). The three most frequently
used enhancement strategies were training manuals
(n = 148), reminder checklists (n = 137) and treatment
manuals or scripted curriculums (n = 116).
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Of the 82 participants with no previous experience of
the use of fidelity strategies, 42.7% (n = 35) were unsure
whether fidelity strategies were discussed at any stage of
trials in which they were involved; 40.2% (n = 33) had
never discussed fidelity strategies; 17.1% (n = 14)
responded that they were discussed but subsequently
not used. The main reasons fidelity strategies were re-
portedly discussed and not used were organised into cat-
egories using content analysis (Additional file 2). The
most reported category was “difficulty implementing fi-
delity strategies” (35.7%, n = 5). The full response is pre-
sented in Fig. 3.
A total of 263 participants responded that they con-
sider or evaluate intervention fidelity during critical ap-
praisal of other trials of complex interventions on an
average frequency of 3.07 (SD 1.31), on a five-point scale
from 1 (never) to 5 (always).
Of the 258 participants who responded to a question
on the use of fidelity frameworks, 73.6% (n = 190) had
never used a specific fidelity tool or framework. Frame-
works or tools that had been used by remaining partici-
pants are specified in Table 3. Overall, 15 frameworks
Table 1 Participant demographics
Variable Mean ± SD
(range)
Age (years) 40.63 ± 11.03
Years of research experience total 11.73 ± 8.67
Years of research experience specific to trials of
complex healthcare interventions
7.32 ± 6.75
(18–73)
Variable N (%)
Gender
Female 203 (76.9)
Male 60 (22.7)
Prefer not to say 1 (0.4)
Country
Republic of Ireland 91 (34.5)
England 66 (25.9)
Scotland 31 (11.7)
Canada 31 (11.7)
Australia 11 (4.2)
Wales 8 (3.0)
Northern Ireland 6 (2.3)
USA 5 (1.9)
Denmark 4 (1.5)
Norway 3 (1.1)
The Netherlands 2 (0.8)
Switzerland 1 (0.4)
Ethiopia 1 (0.4)
South Africa 1 (0.4)
Italy 1 (0.4)
Prefer not to say 2 (0.8)
Level of qualification
PhD 127 (48.1)
Masters degree 88 (33.3)
Undergraduate degree 38 (14.4)
MD 9 (3.4)
None 1 (0.4)
Prefer not to say 1 (0.4)
Area of research
Multidisciplinary (any combination of categories) 116 (43.6)
Medical 43 (16.2)
Allied health professionals 29 (10.9)
Health services research 21 (7.9)
Medical and health professionals (i.e. any
combination of Medical, Nursing and Allied health)
16 (6)
Nursing/midwifery 14 (5.3)
Psychology 11 (4.1)
Public health 8 (3)
Public health and health services research 5 (1.9)
Table 1 Participant demographics (Continued)
Other 3 (1.1)
Level of involvement with trials
Researcher 174 (65.9)
Principal investigator 78 (29.5)
Research practitioner 52 (19.7)
Trial methodologist 42 (15.9)
Student 37 (14.0)
Practitioner 27 (10.2)
Manager/co-ordinator 23 (8.7)
Epidemiologist 9 (3.4)
Statistician 3 (1.1)
Other 11 (4.2)
Aspect of trials involvement
Data collection 237 (89.8)
Design/development 201 (76.1)
Reporting 194 (73.5)
Data analysis 177 (67.0)
Delivering the intervention 159 (60.2)
Other 12 (4.5)
Previous training/research in intervention fidelity
Never received any formal or informal training 137 (51.7)
Informal self-directed research 83 (31.6)
Formal teaching (e.g. lectures, seminars) 24 (9.1)
Formal research (e.g. PhD, MSc) 20 (7.6)
Unsure 1 (0.4)
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were identified by participants. The three most frequently
used frameworks were the Updated NIHBCC Treatment
Fidelity Framework (n = 26) [16], the Conceptual Frame-
work for Implementation Fidelity (n = 26) and the
NIHBCC Treatment Fidelity Framework (n = 19) [15].
A total of 261 participants selected barriers and facili-
tators to enhancing, addressing or reporting intervention
fidelity in trials of complex healthcare interventions, the
results of which are included in Tables 4 and 5. There
was no difference in the most commonly identified bar-
riers and facilitators for people with an above average
understanding/knowledge of fidelity (i.e. mean 5.84)
compared to those with a below average score.
When asked to rate the most important barriers and
facilitators, 170 participants ranked time constraints
(n = 71), lack of knowledge/understanding (n = 64) and
cost (n = 59) as the top barriers. The top three facilita-
tors as ranked by 161 respondents were: availability of
validated tools or checklists (n = 61), good knowledge
of how to assess or enhance fidelity (n = 54), and avail-
ability of funding (n = 48).
Attitudes
The majority of participants either rated fidelity as “Very
Important” (57.1%, n = 149) or “Important” (33%, n =
86), with 260 participants rating the importance of inter-
vention fidelity in trials of complex interventions as high
(mean 4.47 ± 0.67 on a scale of 1–5). There was no asso-
ciation between years of trials-specific research experi-
ence and attitudes (i.e. perceived importance) towards
fidelity (rho = .093 n = 260, p = .137); however, there was
a significant difference in attitudes based on qualification
level (F (3, 30.45) = 4.808, p = .007). Participants with a
PhD or DPhil perceived fidelity as more important (M =
4.62, SD = 0.61) than people with a postgraduate qualifi-
cation (M = 4.33, SD = 0.84) or those achieving up to an
Fig. 1 Most commonly endorsed components of intervention fidelity. *NIHBCC domain. **Other = “Determining if fidelity is not delivered if the
alternative practice is effective and if so why or why not’ (n = 1), ‘Acceptability of intervention to participants and providers” (n = 1),
“Reproducibility” (n = 1), “Ensuring the fidelity criteria are laid out a priori and don’t shift during intervention delivery” (n = 1)
Fig. 2 Frequency of use of assessment strategies, enhancement strategies and reporting
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undergraduate qualification (M= 4.13, SD = 0.97). There
was also a significant difference in attitudes towards fidel-
ity based on research area (F (9, 28.244) = 2.93, p = .014).
Participants in the combined group “medical and health
professionals” (M= 3.56, SD = 1.26) reported perceiving fi-
delity as less important than allied health professionals
(M = 4.69, SD = 0.47), psychology (M= 4.67, SD = 0.50),
public health (M= 4.88, SD = 0.35), nursing/midwifery (M
= 4.43, SD = 0.65), health services research (M4.62, SD =
0.59) and multidisciplinary (M= 4.53, SD = 0.63). No other
significant differences were observed. In terms of training,
89.7% (n = 236) responded that they would welcome train-
ing if it was available, with workshops (n = 177), webinars
(n = 163) and online courses (n = 163) rated as the most
popular, followed by seminars (n = 119), lectures (n = 97)
and conference presentations (n = 1). Reasons provided by
the remaining 10.3% (n = 27) for not wanting further
training were cited as a lack of relevance to work (n = 12),
having sufficient understanding or access to online
information already (n = 12), time constraints (n = 7), be-
ing retired (n = 2), having other priorities (n = 1), or not
considering it important (n = 1).
Thirty-two participants provided additional comments
related to attitudes about intervention fidelity (provided in
Additional file 2). Results of content analysis indicated
that these mostly focused on the importance of interven-
tion fidelity, practicalities, issues regarding terminology/
definitions and the need for further training. Sample
quotes from this content analysis are provided in Table 6.
Discussion
This is the first survey of intervention fidelity amongst
those involved in the development, conduct and evaluation
of trials of complex healthcare interventions. The survey
provides insight into past and current intervention fidelity
practices, knowledge and attitudes. Findings highlight an
awareness of intervention fidelity and its importance
amongst those with experience of trials of complex inter-
ventions, but also a lack of knowledge and need for further
training and education in intervention fidelity. The find-
ings further demonstrated a discrepancy between use and
reporting of fidelity strategies, and a need for practical
guidance and information to improve research in this area.
The findings of this survey clearly show that a lack of
knowledge and understanding is one of the key chal-
lenges to intervention fidelity. Over 90% of the partici-
pants in this study were aware of intervention fidelity or
a similar term; however, self-reported understanding was
rated as only slightly above average. Although partici-
pants with more years of trial-specific experience re-
ported better knowledge, issues relating to knowledge
and understanding were the most frequently reported
barriers and facilitators of intervention fidelity by partici-
pants regardless of their self-reported understanding.
These issues were also ranked as the most important
barriers and facilitators. Perepletchikova et al. and
Cochrane et al. similarly found lack of knowledge to be
a barrier to “treatment integrity” procedures amongst
psychotherapy researchers [27] and teachers involved in
intervention provision, respectively [28]. However, the
lack of specific theory and guidance and resource issues
such as time and cost were found to be stronger barriers
for psychotherapy research [27]. As intervention fidelity
emerged earlier in psychotherapy literature [11, 21, 32],
this may account for this slight difference in findings,
reflecting the differing survey populations. Nonetheless,
barriers relating to the lack of practical guidance and re-
sources were also found to be important in our survey.
Again, in keeping with findings by Perepletchikova et al.
and Cochrane et al. [27, 28], participants in our survey
felt that intervention fidelity was highly important, re-
gardless of their years of trials experience, with zero par-
ticipants designating intervention fidelity as “of little or
Table 2 Fidelity strategies previously used by participants
Fidelity strategies Number (%)
Assessment strategies
Provider self-report record 115 (63.5)
Direct observation 106 (58.6)
Participant interview 106 (58.6)
Provider interview 81 (44.8)
Participant self-report record 73 (40.3)
Audio recording 67 (37)
Participant follow up visits 57 (31.5)
Exit questionnaires 56 (30.9)
Video recording 27 (14.9)
None 1 (0.6)
Other 8 (4.4)
Simulated patients 1 (0.6)
Audit or chart review 2 (1.1)
Web analytics (digital interventions) 3 (1.7)
Blood tests 1 (0.6)
Use of validated fidelity measures 1 (0.6)
Enhancement strategies
Training manual 148 (81.3)
Treatment manual/scripted curriculum/standard operating
procedures
118 (64.8)
Reminder checklists 137 (75.3)
Protocol review group 84 (46.2)
None 4 (2.2)
Other 7 (3.8)
Ongoing support/supervision for providers 2 (1.1)
Observation/audit of providers delivering intervention 3 (1.6)
Colour coding materials for providers 1 (0.5)
Interim analysis 1 (0.5)
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no importance”. Although participants with a doctoral
level of qualification had better self-reported under-
standing and rated fidelity as more important than those
at an undergraduate or postgraduate level, this may re-
flect the deeper level of reflection and engagement with
research that is typically expected at doctoral level stud-
ies. Nonetheless, with the majority of participants rating
it as important but reporting poor knowledge and key
barriers relating to knowledge and understanding, it is
clear that additional training and education in interven-
tion fidelity is both needed and wanted. This is further evi-
denced by the fact that almost 90% of participants
reported they would avail of such training. As both know-
ledge and attitudes towards fidelity seemed to be some-
what lower in areas involving medical research,
developing training that clearly highlights the relevance of
intervention fidelity for all applicable research areas from
the outset and utilises appropriate examples from medical
research as well as other areas, may be warranted.
The variability in participants’ perceptions of the com-
ponents of fidelity provides evidence that conceptualisa-
tion of intervention fidelity often varies between
researchers. This finding is perhaps unsurprising given
the lack of consensus in the literature on fidelity defini-
tions, terminology and conceptualisations [4]; however,
this discrepancy makes it difficult to move the science
forward [19]. That “treatment delivery” was the most fre-
quently endorsed component of intervention fidelity is
perhaps unsurprising, as delivering the treatment as
intended represents where intervention fidelity literature
originated [15, 21], and is the most frequently measured
or reported domain of intervention fidelity [8, 14, 24]. A
small number of participants in this study (n = 20) felt
treatment delivery was the only component of fidelity,
perhaps representing a somewhat limited view of inter-
vention fidelity. However, as previously mentioned,
intervention fidelity has essentially evolved into a
multi-component, multidimensional concept, enabling a
more comprehensive understanding of the intervention
process [15]; this likely adds to the confusion evidenced by
the participants in this survey. However, it may also be the
case that participants were aware of the different compo-
nents provided, but may not have agreed with their inclu-
sion within the concept of intervention fidelity. For
example, the most infrequently selected fidelity component
was enactment, potentially in line with previous arguments
that treatment enactment is a measure of treatment effect-
iveness and not fidelity [24]. This finding was also echoed
in two recent systematic reviews of fidelity within complex
interventions by O’Shea et al. [8] and Lambert et al., [14]
who both found treatment enactment to be infrequently
measured, carried out in only 10 out of 65 and 8 out of 21
included studies, respectively. Overall, the variability in se-
lected components of fidelity, in addition to participants’
low self-reported understanding score, suggest an overall
lack of clarity in this population on what intervention fidel-
ity is and what it encompasses. As the majority of partici-
pants felt that a clear understanding of the definition was a
facilitator to intervention fidelity in this area, it would ap-
pear that a universally agreed upon definition and concep-
tualisation of intervention fidelity is essential to improving
knowledge, understanding and practice of fidelity in trials
of complex interventions.
The findings of this survey also highlight disparities
between participants’ use of fidelity strategies and their
subsequent reporting of these strategies in publication.
A commonly cited limitation of many systematic reviews
that have evaluated fidelity practices is that it is often
Fig. 3 Reasons fidelity strategies were discussed and not used
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unclear whether intervention fidelity was poorly addressed
or just poorly reported in published intervention studies
[4, 8, 10]. This survey provides evidence that even when
strategies to enhance and assess intervention fidelity are
utilised within trials of complex interventions, they are
not always subsequently reported. In our survey, partici-
pants identified 14 ways to assess fidelity and 8 ways to
enhance fidelity in trials. Adequate reporting of any such
methods that are used facilitates optimal selection of strat-
egies for researchers involved in future trials, and provides
more information on how to choose these more appropri-
ately [4, 17]. Although reporting of intervention fidelity
may be influenced by issues such as space restrictions and
lack of journal reporting requirements [27], these were
not the most common nor the most important perceived
barriers or facilitators identified in this study. Therefore,
although we support previous recommendations for jour-
nals to request fidelity details and provide space for
reporting [4], it may be more of a research priority to fa-
cilitate a more standardised approach to reporting fidelity.
This could be done through the development of specific
fidelity reporting criteria, or expansion of existing criteria
such as items 11 and 12 of the Template for intervention
description and replication (TIDiER) guidelines [33], so
that researchers are equipped with more accurate and
up-to-date knowledge of what to report and how.
The importance of tools or checklists and practical guid-
ance recurred throughout the survey data, with the avail-
ability of these items featuring amongst the most important
and most frequently reported facilitators. Despite this find-
ing, the majority of participants had never used a validated
framework or tool such as the NIHBCC fidelity framework
[9] or the Conceptual Framework for Implementation Fi-
delity [2], which were the most commonly identified frame-
works by those who had used one. Previous research has
similarly found that fidelity frameworks are underused in
behaviour change interventions, despite their availability
and importance [8, 13]. Although O’Shea and colleagues
suggested that their underuse may have been due to lack of
resources [8], the findings of this survey posit that a lack of
awareness of such tools may also be an issue. Our findings
also suggest that suboptimal use of such frameworks may
also be due to a lack of usability or practicality issues, an
issue highlighted recently by Walton et al., who found that
only 26% of health behaviour change interventions focused
on acceptability and practicality of fidelity assessment mea-
sures [13]. Previous studies that have used the NIHBCC
framework have also highlighted issues in relation to ambi-
guity of components [34], or a lack of practical guidance in
terms of how to incorporate actual fidelity scores [35].
Moreover, neither the NIHBCC nor the Conceptual Frame-
work for Implementation Fidelity framework provide suffi-
cient guidance on how to balance fidelity with adaptation.
This is an issue of vital importance within this area [36–
38], briefly alluded to by one participant in the additional
comments regarding the need for pragmatism over strict fi-
delity. These frameworks also do not discuss weighting of
components, making it difficult for researchers to deter-
mine which intervention fidelity components to prioritise if
limited for time or resources. With time and funding fea-
turing amongst the most important barriers and facilitators,
our findings echo previous research, which identifies time,
labour and cost to be strong barriers to intervention fidelity
[27, 39]. As such, future research should focus on develop-
ing practical guidance and/or improving existing frame-
works to address intervention fidelity in trials in a way that
considers the issue of adaptation and is mindful of time
and cost issues for researchers.
Study limitations
In this survey, barriers and facilitators to enhancing, asses-
sing and reporting intervention fidelity were explored
Table 3 Use of fidelity frameworks/tools
Number (%)
2011 Updated NIHBCC Treatment
Fidelity Framework [16]
26 (10.1)
Conceptual Framework for
Implementation Fidelity
26 (10.1)
2004 NIHBCC Treatment
Fidelity Framework [15]
19 (7.4)
Unsure/do not know 6 (2.3)
Comprehensive Intervention
Fidelity Guide [24]
5 (1.9)
Other 15 (5.8)
Medical Research Council
Guidance on Process Evaluation
of Complex Interventions [40]
3 (1.2)
TIDieR checklist 2 (0.8)
Developed specifically for study 1 (0.4)
Multiple “ad hoc”
publications consulted
1 (0.4)
RE-AIM framework [41] 1 (0.4)
Framework/Taxonomy
of Implementation [42]
1 (0.4)
Precede-Proceed [43] 1 (0.4)
Conceptual Framework
of Implementability [44]
1 (0.4)
Process Evaluation
“How-to” Guide [45]
1 (0.4)
BCT Taxonomy v1 [46] 1 (0.4)
Karas and Plankis 2016 [47] 1 (0.4)
Durlak and DuPre 2008 [48] 1 (0.4)
SPIRIT Intervention Fidelity Assessment Tool [49] 1 (0.4)
NIHBCC National Institutes of Health Behaviour Change Consortium,
BCT behaviour change techniques, TIDieR Template for intervention
description and replication, RE-AIM Reach Effectiveness Adoption
Implementation Maintenance
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concurrently. However, barriers may be experienced
differently for these aspects, for example, time re-
straints may be a bigger barrier to using assessment
strategies (i.e. conducting direct observations) than to
enhancing fidelity (i.e. using a treatment manual). Fu-
ture research could therefore explore the barriers and
facilitators more specifically to each aspect individu-
ally. Due to limited resources, psychometric testing
was not carried out on survey questions. Moreover,
survey questions were predominantly informed by the
NIHBCC conceptualisation of intervention fidelity,
which may have influenced findings. However, other
predominant fidelity literature and conceptualisations
were utilised in the questionnaire development and
questions were piloted to minimise the potential for
bias. Additionally, the majority of respondents were
based in Ireland and the UK, potentially reflecting the
opportunistic nature of the sample and the authors’
locations, and may influence the generalisability of
study findings. However, attempts were made to dis-
seminate the survey as broadly as possible, and a total
of 15 countries were represented in this survey. Add-
itionally, the response rate from organisations con-
tacted was low (14%), which may also impact the
generalisability of our findings. This low response rate
perhaps demonstrates low interest in the important
issue of intervention fidelity amongst the wider com-
plex healthcare intervention research community.
However, no reminder emails were sent and the ma-
jority of these organisations were contacted using
generic public email addresses where the initial con-
tact point may not have been a researcher or had
much involvement with complex healthcare interven-
tion research, therefore the survey link or information
about the study may not have reached the relevant
parties. It must also be acknowledged that those who
participated in this survey may have been more inter-
ested in intervention fidelity from the outset, i.e. a
self-selection bias meaning that those with the most
interest and awareness of fidelity were most likely to
complete the survey. Nonetheless, this means our
findings likely represent a best-case scenario and the
lack of awareness and use of fidelity in the wider
Table 4 Most frequently identified barriers to enhancing,
addressing or reporting intervention fidelity
Barrier Number (%)
Poor knowledge or understanding 202 (77.4)
Lack of practical guidance 167 (64)
Lack of criteria specifying
acceptable levels
164 (62.8)
Inconsistent terminology 148 (56.7)
Time restraints 131 (50.2)
Lack of perceived importance 129 (49.4)
Inconsistent definitions 112 (42.9)
Lack of agreement around
appropriate strategies
109 (41.8)
Core components of
interventions
not sufficiently identified
105 (40.2)
Cost 97 (37.2)
Lack of journal requirement
for publication
92 (35.2)
Resistance to monitoring/assessment
by providers
82 (31.4)
Resistance to the use of
treatment manuals by providers
79 (30.3)
Space limitations for publication 77 (29.5)
None 1 (0.4)
Othera 12 (4.6)
“Real-world” complexity and constraints 4 (1.6)
Difficulty quantifying fidelity data 3 (1.2)
Willingness of principal investigator 2 (0.8)
Insufficient teaching/education 1 (0.4)
Rigidity/lack of flexibility may limit patient care 1 (0.4)
Practitioners’ desire for independence 1 (0.4)
aAdditional barriers identified by participants
Table 5 Most frequently identified facilitators to enhancing,
addressing or reporting intervention fidelity
Facilitator Number (%)
Knowledge of how to assess or enhance 209 (80.1)
Availability of validated tools or checklists 202 (77.4)
Availability of practical guidance 180 (69)
Clear understanding of the definition 168 (64.4)
Perceived importance by researchers 164 (62.8)
Funding or monetary resources 136 (52.1)
Perceived importance by academic journals 132 (50.6)
Accessibility of methodologists
or people with specific fidelity expertise
123 (47.1)
Availability of reporting criteria 121 (46.4)
Time 114 (43.7)
Priority given by journals 84 (32.2)
Do not know 2 (0.8)
Othera 7 (2.7)
Perceived importance by funders 2 (0.8)
Perceived importance by providers 2 (0.8)
Perceived importance by principal investigators 1 (0.4)
Translation from research to real world setting 1 (0.4)
Training 1 (0.4)
aAdditional facilitators identified by participants
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complex healthcare intervention literature is actually
higher. However, if this is the case, it further empha-
sises the recommendations from this study, highlight-
ing the need for further research and training to
increase awareness and understanding of this import-
ant issue. Furthermore, participants in this survey had
variable levels of education and experience specific to
intervention fidelity as well as representing a broad
range of trial involvement and multidisciplinary re-
search areas, which enhances the generalisability of
the study findings.
Conclusions
Despite good awareness of intervention fidelity and its im-
portance, poor knowledge and understanding appears to
be a substantial limitation in how intervention fidelity is
being addressed in trials of complex healthcare interven-
tions. Clarification and universal agreement around the
terminology, definition and components of intervention fi-
delity would facilitate better understanding of the concept.
Participants identified a need for training in this area, and
felt that practical guidance on how to assess, enhance or
report fidelity in trials of complex interventions is lacking.
Discrepancies between participants’ previous use of fidel-
ity strategies and subsequent reporting highlights the issue
of inadequate intervention fidelity reporting, identifying a
further area for future development.
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Table 6 Additional comments regarding intervention fidelity
Theme identified (number of
participants)
Sample quotes
Importance of
intervention fidelity
(n = 18)
“This is an important and
interesting aspect to clinical trials …”
“… an important issue,
may undermine the lack of
findings from some trials”
“I think fidelity is central
to the findings of any complex
trial. I am a strong advocate …”
“… an incredibly important area of
research”
Practicalities (n = 7) “It is difficult to assess treatment
fidelity as the resource needed to
do this properly is quite significant …”
“Pragmatism has to trump strict
adherence/fidelity in complex
healthcare interventions …”
“Ideally, complex intervention
clinical trials should be preceded
by a feasibility study …”
Terminology/definitions (n = 3) “… it’s not a term that I was
familiar with pre-survey”
“… something that does not
appear to have a clear definition …
I cannot be sure that I have answered
your questions accurately”
Further training (n = 3) “… would gladly apply teaching
regarding this topic”
“Re training: I think it is vital
for young researchers - wish it
had been around when I
was starting out”
McGee et al. Trials  (2018) 19:504 Page 12 of 14
Author details
1School of Medicine, Clinical Science Institute, National University of Ireland
Galway, University Road, Galway, IrelandH91 TK33. 2Centre for Behaviour
Change, University College London, 1-19 Torrington Place, London WC1E
7HB, UK. 3School of Public Health, Western Gateway Building, University
College Cork, Cork, IrelandT12 YN60. 4Health Behaviour Change Research
Group, Room 2058, School of Psychology, Arts Millennium Building, National
University of Ireland Galway, University Road, Galway, IrelandH91 TK33.
Received: 10 January 2018 Accepted: 4 August 2018
References
1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M.
Developing and evaluating complex interventions: the new Medical
Research Council guidance. BMJ. 2008;337:1–6.
2. Carroll C, Patterson M, Wood S, Booth A, Rick J, Balain S. A conceptual
framework for implementation fidelity. Implement Sci. 2007;2:40.
3. Perepletchikova F, Kazdin AE. Treatment integrity and therapeutic
change: issues and research recommendations. Clin Psychol Sci Pract.
2005;12:365–83.
4. Slaughter SE, Hill JN, Snelgrove-Clarke E. What is the extent and quality of
documentation and reporting of fidelity to implementation strategies: a
scoping review. Implement Sci. 2015;10:129.
5. Toomey E, Matthews J, Guerin S, Hurley DA. Development of a feasible
implementation Fidelity protocol within a complex physical therapy–led
self-management intervention. Phys Ther. 2016;96:1287–98.
6. Dusenbury L, Brannigan R, Falco M, Hansen W. A review of research on
fidelity of implementation: implications for drug abuse prevention in school
settings. Health Educ Res. 2003;18:237–56.
7. Breitenstein SM, Gross D, Garvey C, Hill C, Fogg L, Resnick B.
Implementation Fidelity in community-based interventions. Res Nurs Health.
2010;33:164–73.
8. O’Shea O, McCormick R, Bradley JM, O’Neill B. Fidelity review: a scoping
review of the methods used to evaluate treatment fidelity in behavioural
change interventions. Phys Ther Rev. 2016;21:207–14.
9. Borrelli B, Sepinwall D, Ernst D, Bellg AJ, Czajkowski S, Breger R, DeFrancesco
C, Levesque C, Sharp DL, Ogedegbe G, et al. A new tool to assess treatment
fidelity and evaluation of treatment fidelity across 10 years of health
behavior research. J Consult Clin Psychol. 2005;73:852–60.
10. Toomey E, Currie-Murphy L, Matthews J, Hurley DA. Implementation fidelity
of physiotherapist-delivered group education and exercise interventions to
promote self-management in people with osteoarthritis and chronic low
back pain: a rapid review part II. Man Ther. 2015;20:287–94.
11. Moncher FJ, Prinz RJ. Treatment fidelity in outcome studies. Clin Psychol
Rev. 1991;11:247–66.
12. Schinckus L, Broucke S, Housiaux M. Assessment of implementation fidelity
in diabetes self-management education programs: a systematic review.
Patient Educ Couns. 2014;96:13–21.
13. Walton H, Spector A, Tombor I, Michie S. Measures of fidelity of delivery of,
and engagement with, complex, face-to-face health behaviour change
interventions: a systematic review of measure quality. Br J Health Psychol.
2017;22:872–903.
14. Lambert JD, Greaves CJ, Farrand P, Cross R, Haase AM, Taylor AH.
Assessment of fidelity in individual level behaviour change interventions
promoting physical activity among adults: a systematic review. BMC Public
Health. 2017;17:765.
15. Bellg A, Borrelli B, Resnick B, Hecht J, Minicucci D, Ory M, Ogedegbe G,
Orwig D, Ernst D, Czajkowski S. Enhancing treatment fidelity in health
behavior change studies: best practices and recommendations from the
NIH behavior change consortium. Health Psychol. 2004;23:443–51.
16. Borrelli B. The assessment, monitoring, and enhancement of treatment
fidelity in public health clinical trials. J Public Health Dent. 2011;71:S52–63.
17. Robb SL, Burns DS, Docherty SL, Haase JE. Ensuring treatment fidelity in a multi-
site behavioral intervention study: implementing NIH behavior change
consortium recommendations in the SMART trial. Psycho-Oncology. 2011;20:
1193–201.
18. Spillane V, Byrne MC, Byrne M, Leathem CS, O’Malley M, Cupples ME.
Monitoring treatment fidelity in a randomized controlled trial of a complex
intervention. J Adv Nurs. 2007;60:343–52.
19. Montgomery P, Underhill K, Gardner F, Operario D, Mayo-Wilson E. The Oxford
implementation index: a new tool for incorporating implementation data into
systematic reviews and meta-analyses. J Clin Epidemiol. 2013;66:874–82.
20. Di Rezze B. Ensuring intervention fidelity in rehabilitation research. CanChild
Centre for Childhood Disability Research. 2012;38. Available at: https://www.
canchild.ca/en/resources/38-ensuring-intervention-fidelity-in-rehabilitation-
research.
21. Yeaton WH, Sechrest L. Critical dimensions in the choice and maintenance
of successful treatments: strength, integrity, and effectiveness. J Consult Clin
Psychol. 1981;49:156–67. https://www.canchild.ca/en/resources/38-ensuring-
intervention-fidelity-in-rehabilitation-research.
22. Lichstein KL, Riedel BW, Grieve R. Fair tests of clinical trials: a treatment
implementation model. Adv Behav Res Ther. 1994;16:1–29.
23. Dane A, Schneider B. Program integrity in primary and early secondary
prevention: are implementation effects out of control. Clin Psychol Rev.
1998;18:23–45.
24. Gearing RE, El-Bassel N, Ghesquiere A, Baldwin S, Gillies J, Ngeow E. Major
ingredients of fidelity: a review and scientific guide to improving quality of
intervention research implementation. Clin Psychol Rev. 2011;31:79–88.
25. Prowse PT, Nagel T. A meta-evaluation: the role of treatment fidelity
within psychosocial interventions during the last decade. J Psychiatry.
2015;18:1–7.
26. Parham LD, Cohn ES, Spitzer S, Koomar JA, Miller LJ, Burke JP, Brett-Green B,
Mailloux Z, May-Benson TA, Roley SS, et al. Fidelity in sensory integration
intervention research. Am J Occup Ther. 2007;61:216–27.
27. Perepletchikova F, Hilt LM, Chereji E, Kazdin AE. Barriers to implementing
treatment integrity procedures: survey of treatment outcome researchers.
J Consult Clin Psychol. 2009;77:212–8.
28. Cochrane WS, Laux JM. Investigating school psychologists’ perceptions of
treatment integrity in school-based interventions for children with
academic and behavior concerns. Prev Sch Fail. 2007;51:29–34.
29. Smith OM, Dale C, Mehta S, Pinto R, Rose L. Nurse research experiences and
attitudes toward the conduct of intensive care research: a questionnaire
study. Crit Care Med. 2016;44:153–61.
30. O’Donnell CL. Defining, conceptualizing, and measuring fidelity of
implementation and its relationship to outcomes in K–12 curriculum
intervention research. Rev Educ Res. 2008;78:33–84.
31. Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis.
Qual Health Res. 2005;15:1277–88.
32. Waltz J, Addis ME, Koerner K, Jacobson NS. Testing the integrity of a
psychotherapy protocol: assessment of adherence and competence. J
Consult Clin Psychol. 1993;61:620–30.
33. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman D,
Barbour V, Macdonald H, Johnston M, et al. Better reporting of
interventions: template for intervention description and replication (TIDieR)
checklist and guide. BMJ. 2014;348:1–12.
34. Preyde M, Burnham PV. Intervention fidelity in psychosocial oncology. J Evid
Based Soc Work. 2011;8:379–96.
35. Johnson-Kozlow M, Hovell MF, Rovniak LS, Sirikulvadhana L, Wahlgren DR,
Zakarian JM. Fidelity issues in secondhand smoking interventions for
children. Nicotine Tob Res. 2008;10:1677–90.
36. Holliday J, Audrey S, Moore L, Parry-Langdon N, Campbell R. High fidelity?
How should we consider variations in the delivery of school-based health
promotion interventions? Health Educ J. 2009;68:44–62.
37. Mowbray CT, Holter MC, Teague GB, Bybee D. Fidelity criteria: development,
measurement, and validation. Am J Eval. 2003;24:315–40.
38. McHugh RK, Murray HW, Barlow DH. Balancing fidelity and adaptation in
the dissemination of empirically-supported treatments: the promise of
Transdiagnostic interventions. Behav Res Ther. 2009;47:946–53.
39. Sanetti LMH, DiGennaro Reed FD. Barriers to implementing treatment integrity
procedures in school psychology research. Assess Eff Interv. 2012;37:195–202.
40. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L,
O’Cathain A, Tinati T, Wight D, Baird J. Process evaluation of complex
interventions: Medical Research Council guidance. BMJ. 2015;350:1–7.
41. Glasgow R, Vogt T, Boles S. Evaluating the public health impact of health
promotion interventions: the RE-AIM framework. Am J Public Health. 1999;
89:1322–7.
42. Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations
for specifying and reporting. Implement Sci. 2013;8:65–6.
43. Green L, Kreuter M. Health promotion planning: an educational and
environmental approach. Mountain View: Mayfield Publishing; 1991.
McGee et al. Trials  (2018) 19:504 Page 13 of 14
44. Gagliardi AR, Brouwers MC, Palda VA, Lemieux-Charles L, Grimshaw JM. How
can we improve guideline use? A conceptual framework of implementability.
Implement Sci. 2011;9:e108585.
45. Saunders R, Evans M, Joshi P. Developing a process-evaluation plan for
assessing health promotion program implementation: a how-to guide.
Health Promot Pract. 2005;6:134–47.
46. Michie S, van Stralen MM, West R. The behaviour change wheel: a new
method for characterising and designing behaviour change interventions.
Implement Sci. 2011;6:2-11.
47. Karas S, Plankis L. Consideration of treatment fidelity to improve manual
therapy research. J Man Manip Ther. 2016;24:233–7.
48. Durlak JA, DuPre EP. Implementation matters: a review of research on the
influence of implementation on program outcomes and the factors
affecting implementation. Am J Community Psychol. 2008;41:327–50.
49. Song M-K, Happ MB, Sandelowski M. Development of a tool to assess
fidelity to a psycho-educational intervention. J Adv Nurs. 2010;66:673–82.
McGee et al. Trials  (2018) 19:504 Page 14 of 14
